Cargando…

Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma

BACKGROUND: Early-stage lung squamous cell carcinoma (LUSC) progression is accompanied by changes in immune microenvironments and the expression of immune-related genes (IRGs). Identifying innate IRGs associated with prognosis may improve treatment and reveal new immunotherapeutic targets. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Liang, Yu, Xue, Ma, Guanqiang, Ji, Zhiqi, Bao, Shihao, He, Xiaopeng, Song, Liang, Yu, Yang, Shi, Mo, Liu, Xiangyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643179/ https://www.ncbi.nlm.nih.gov/pubmed/34876838 http://dx.doi.org/10.2147/IJGM.S341175

Ejemplares similares

Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma
por: Zhang, Suwei, et al.
Publicado: (2022)

Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma
por: Zou, Chen, et al.
Publicado: (2021)

Immune classification and identification of prognostic genes for uveal melanoma based on six immune cell signatures
por: Gao, Guohong, et al.
Publicado: (2021)

Downregulation of fibulin‐4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt‐mTOR signaling pathway
por: Chen, Xiangyu, et al.
Publicado: (2022)

Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma
por: Tang, Rui-Xue, et al.
Publicado: (2017)

Identification of a three-gene prognostic signature for radioresistant esophageal squamous cell carcinoma
por: Wang, Xiao-Yan, et al.
Publicado: (2023)

Identification of a prognostic immune‐related signature for small cell lung cancer
por: Xie, Qi, et al.
Publicado: (2021)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma
por: Xiong, Kai, et al.
Publicado: (2022)

Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma
por: Ouyang, Fu-Sheng, et al.
Publicado: (2017)

Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes
por: Mo, Bin-Yu, et al.
Publicado: (2020)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
por: Zhao, Mengnan, et al.
Publicado: (2022)

Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Xing, Chaoqun, et al.
Publicado: (2022)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma
por: Wang, Yingying, et al.
Publicado: (2020)

Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics
por: Zhang, Yang-Yang, et al.
Publicado: (2021)

Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma
por: Ji, Yanping, et al.
Publicado: (2020)

Prognostic signature related to the immune environment of oral squamous cell carcinoma
por: Hua, Yingjie, et al.
Publicado: (2022)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma
por: Lv, Shaohua, et al.
Publicado: (2022)

Identification of novel subtypes based on ssGSEA in immune‐related prognostic signature for tongue squamous cell carcinoma
por: Jin, Yi, et al.
Publicado: (2021)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Construction of a prognostic immune-related lncRNA model and identification of the immune microenvironment in middle- or advanced-stage lung squamous carcinoma patients
por: Xue, Qianqian, et al.
Publicado: (2022)

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
por: Chen, Rui-Lian, et al.
Publicado: (2020)

Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma
por: Zhang, Yiping, et al.
Publicado: (2023)

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
por: Fan, Tao, et al.
Publicado: (2021)

Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma
por: Zhang, Fujun, et al.
Publicado: (2020)

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Construction and Identification of an NLR-Associated Prognostic Signature Revealing the Heterogeneous Immune Response in Skin Cutaneous Melanoma
por: Geng, Yi, et al.
Publicado: (2023)

Identification of a prognostic six-immune-gene signature and a nomogram model for uveal melanoma
por: Yang, Binghua, et al.
Publicado: (2023)

Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma
por: Wang, Wentao, et al.
Publicado: (2023)

Innate immunity and immunotherapy for hemorrhagic shock
por: Huang, Qingxia, et al.
Publicado: (2022)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
por: Liu, Nian, et al.
Publicado: (2020)

Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma
por: Zhu, Chao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vt4t5hqosqumdq7i2lifflgjin